These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11914625)

  • 1. Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival.
    Hilton DA; Penney M; Evans B; Sanders H; Love S
    Am J Surg Pathol; 2002 Apr; 26(4):472-8. PubMed ID: 11914625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
    Hara A; Saegusa M; Ichinoe M; Okayasu I
    J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
    Miettinen H; Kononen J; Sallinen P; Alho H; Helen P; Helin H; Kalimo H; Paljärvi L; Isola J; Haapasalo H
    J Neurooncol; 1999 Feb; 41(3):205-11. PubMed ID: 10359140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers.
    Hommura F; Dosaka-Akita H; Kinoshita I; Mishina T; Hiroumi H; Ogura S; Katoh H; Kawakami Y
    Br J Cancer; 1999 Oct; 81(4):696-701. PubMed ID: 10574258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Papalazarou D; Rontogianni D; Arvanitis D; Antonakopoulos G; Gorgoulis V; Bai M; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4619-25. PubMed ID: 11205312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
    Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L
    J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between p16 and Rb protein expression in astrocytomas].
    Lin Y; Huang C; Liu D
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):340-2. PubMed ID: 10374322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP).
    Travaglino A; Raffone A; Gencarelli A; Neola D; Oliviero DA; Alfano R; Campanino MR; Cariati F; Zullo F; Mollo A; Insabato L
    Pathol Res Pract; 2021 Oct; 226():153592. PubMed ID: 34481212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
    Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers relating to malignant progression in Grade II astrocytoma.
    Yue WY; Yu SH; Zhao SG; Chen ZP
    J Neurosurg; 2009 Apr; 110(4):709-14. PubMed ID: 19025355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
    Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
    Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.